Healthcare Sector Review: Winning and Losing Stocks

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • MannKind Corporation (NASDAQ:MNKD): The shares closed at $3.74, up $0.56, or 17.61%, on the day. Its market capitalization is $489.82 million. About the company: MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.
  • Infinity Pharmaceuticals (NASDAQ:INFI): The shares closed at $6.75, up $0.58, or 9.4%, on the day. Its market capitalization is $179.57 million. About the company: Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.
  • SIGA Technologies, Inc. (NASDAQ:SIGA): The shares closed at $2.94, up $0.25, or 9.29%, on the day. Its market capitalization is $150.86 million. About the company: SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company’s also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.
  • Hospira, Inc. (NYSE:HSP): The shares closed at $37.41, up $2.97, or 8.62%, on the day. Its market capitalization is $6.17 billion. About the company: Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
  • Corcept Therapeutics Inc. (NASDAQ:CORT): The shares closed at $2.79, up $0.22, or 8.56%, on the day. Its market capitalization is $234.93 million. About the company: Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company’s lead product modulates the effect of cortisol, also known as the “stress hormone”, by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.

Losers (% price change)

  • Orexigen Therapeutics (NASDAQ:OREX): The shares closed at $2.09, down $0.17, or 7.52%, on the day. Its market capitalization is $100.50 million. About the company: Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.
  • Transcend Services, Inc. (NASDAQ:TRCR): The shares closed at $22.69, down $1.59, or 6.55%, on the day. Its market capitalization is $242.14 million. About the company: Transcend Services, Inc. provides patient information management solutions to hospitals and other associated healthcare providers. The Company’s solutions include management of records operations, transcription of physicians’ dictated medical notes, consulting relating to medical records management and reimbursement coding, and software for the management of patient information.
  • Immunomedics, Inc. (NASDAQ:IMMU): The shares closed at $3.30, down $0.2, or 5.71%, on the day. Its market capitalization is $249.05 million. About the company: Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company’s products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.
  • Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $16.08, down $0.79, or 4.68%, on the day. Its market capitalization is $749.38 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.
  • Oncolytics Biotech, Inc (NASDAQ:ONCY): The shares closed at $3.87, down $0.15, or 3.73%, on the day. Its market capitalization is $275.60 million. About the company: Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More Articles About:
Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business